两例具有高危特征的NUTM1重排B细胞急性淋巴细胞白血病新病例。 - Suppr | 超能文献

相似文献

1

Two novel cases of NUTM1-rearranged B-cell acute lymphoblastic leukaemia presenting with high-risk features.两例具有高危特征的NUTM1重排B细胞急性淋巴细胞白血病新病例。

Br J Haematol. 2022 Mar;196(6):1407-1411. doi: 10.1111/bjh.17995. Epub 2021 Dec 12.

2

Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemia.CRLF2重排急性淋巴细胞白血病的基因组图谱特征分析。

Genes Chromosomes Cancer. 2017 May;56(5):363-372. doi: 10.1002/gcc.22439. Epub 2017 Jan 18.

3

Cryptic recurrent ACIN1-NUTM1 fusions in non-KMT2A-rearranged infant acute lymphoblastic leukemia.非 KMT2A 重排婴儿急性淋巴细胞白血病中隐匿性的 ACIN1-NUTM1 融合。

Genes Chromosomes Cancer. 2020 Feb;59(2):125-130. doi: 10.1002/gcc.22808. Epub 2019 Oct 4.

4

Co-occurrence of CRLF2-rearranged and Ph+ acute lymphoblastic leukemia: a report of four patients.CRLF2重排与Ph+急性淋巴细胞白血病并存：4例患者报告

Haematologica. 2017 Dec;102(12):e514-e517. doi: 10.3324/haematol.2016.161000. Epub 2017 Aug 31.

5

BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.BET 溴结构域抑制物靶向高危急性淋巴细胞白血病中的 c-Myc 和 IL7R。

Blood. 2012 Oct 4;120(14):2843-52. doi: 10.1182/blood-2012-02-413021. Epub 2012 Aug 17.

6

Outcomes of adult patients with relapsed/refractory CRLF2 rearranged B-cell acute lymphoblastic leukemia.复发/难治性CRLF2重排的B细胞急性淋巴细胞白血病成年患者的预后

Am J Hematol. 2023 Jun;98(6):E142-E144. doi: 10.1002/ajh.26907. Epub 2023 Mar 16.

7

[Clinical Features and Prognosis of Acute Lymphoblastic Leukemia Children with P2RY8-CRLF2 Gene Rearrangement].P2RY8-CRLF2基因重排的急性淋巴细胞白血病儿童的临床特征与预后

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021 Apr;29(2):311-315. doi: 10.19746/j.cnki.issn.1009-2137.2021.02.001.

8

CRLF2 rearrangement in Ph-like acute lymphoblastic leukemia predicts relative glucocorticoid resistance that is overcome with MEK or Akt inhibition.CRLF2 重排与 Ph 样急性淋巴细胞白血病相关，预示着相对的糖皮质激素耐药，而 MEK 或 Akt 抑制可克服这种耐药性。

PLoS One. 2019 Jul 18;14(7):e0220026. doi: 10.1371/journal.pone.0220026. eCollection 2019.

9

Emerging entities in NUTM1-rearranged neoplasms.NUTM1 重排肿瘤中的新兴实体。

Genes Chromosomes Cancer. 2020 Jun;59(6):375-385. doi: 10.1002/gcc.22838. Epub 2020 Feb 25.

10

Combination efficacy of ruxolitinib with standard-of-care drugs in CRLF2-rearranged Ph-like acute lymphoblastic leukemia.芦可替尼联合标准治疗药物治疗 CRLF2 重排型 Ph 样急性淋巴细胞白血病的疗效。

Leukemia. 2021 Nov;35(11):3101-3112. doi: 10.1038/s41375-021-01248-8. Epub 2021 Apr 24.

引用本文的文献

1

Challenging the prognostic expectations: a rare case of ::-positive B-cell lymphoblastic leukemia with poor outcome.挑战预后预期：一例罕见的预后不良的::阳性B细胞淋巴细胞白血病病例。（注：原文中“::-positive”表述不完整，这里按原样翻译）

Blood Sci. 2025 Mar 19;7(2):e00230. doi: 10.1097/BS9.0000000000000230. eCollection 2025 Jun.

2

Unraveling the Genetic Heterogeneity of Acute Lymphoblastic Leukemia Based on NGS Applications.基于二代测序技术应用解析急性淋巴细胞白血病的遗传异质性

Cancers (Basel). 2024 Nov 26;16(23):3965. doi: 10.3390/cancers16233965.

3

The second adult case of NUTM1 fusion-positive B-cell lymphoblastic leukemia: A recurring pattern of poor prognosis.